Strategies to Treat Osteoporosis Following a Fragility Fracture (OPTIMUS)

This study has been completed.
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Procter and Gamble
Sanofi
Novartis
Amgen
Eli Lilly and Company
Servier
Warner Chilcott
Information provided by (Responsible Party):
Gilles Boire, Université de Sherbrooke
ClinicalTrials.gov Identifier:
NCT00512499
First received: August 3, 2007
Last updated: July 11, 2016
Last verified: July 2016